Patents by Inventor Eiichiro Ishikawa

Eiichiro Ishikawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Method of Treating Hyperlipidemia
    Publication number: 20090209510
    Abstract: A pharmaceutical composition useful for a prevention and/or treatment of hyperlipidemia, which comprises combining an effective amount of squalene synthase inhibitor and HMG-CoA reductase inhibitor is provided.
    Type: Application
    Filed: May 31, 2006
    Publication date: August 20, 2009
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Tomoyuki Nishimoto, Ryuichi Tozawa, Takeo Wada, Eiichiro Ishikawa, Toshiya Nishi, Hiroko Yamakawa
  • Novel polypeptides
    Patent number: 4073890
    Abstract: Novel polypeptides of the formulaR.sub.1 --Arg--R.sub.2 --Phe--Phe--R.sub.3wherein R.sub.1 is hydrogen, or a basic or neutral amino acid residue, R.sub.2 is a neutral amino acid residue and R.sub.3 is NH.sub.2, Tyr--NH.sub.2, a residue of tyrosyl peptides consisting of 1 to 5 amino acid residues or amides of the tyrosyl peptides, provided that when R.sub.1 is hydrogen, R.sub.2 is Pro, are effectively used for treatment of insufficiency of carbohydrate metabolism and of lipid metabolism, especially for the treatment of diabetes by not only parenteral administration but also oral administration.
    Type: Grant
    Filed: September 23, 1976
    Date of Patent: February 14, 1978
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Masahiko Fujino, Mitsuhiro Wakimasu, Shigehisa Taketomi, Eiichiro Ishikawa
  • Novel polypeptides useful for treating diabetes and hypercholesteremia
    Patent number: 4001199
    Abstract: Novel polypeptides of the formulaR.sub.1 --Arg--R.sub.2 --Phe--Phe--R.sub.3wherein R.sub.1 is hydrogen, or a basic or neutral amino acid residue, R.sub.2 is a neutral amino acid residue and R.sub.3 is NH.sub.2, Tyr--NH.sub.2, a residue of tyrosyl peptides consisting of 1 to 5 amino acid residues or amides of the tyrosyl peptides, provided that when R.sub.1 is hydrogen, R.sub.2 is Pro, are effectively used for treatment of insufficiency of carbohydrate metabolism and of lipid metabolism, especially for the treatment of diabetes by not only parenteral administration but also oral administration.
    Type: Grant
    Filed: March 19, 1975
    Date of Patent: January 4, 1977
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Masahiko Fujino, Mitsuhiro Wakimasu, Shigehisa Taketomi, Eiichiro Ishikawa